PayerBiosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?
The U.S. has been slower to adopt biosimilar drugs since the first such medicine was approved in 2015.
StrategyU.S. Prescription Drugs Cost Highest in the World, By Far
A RAND study shows the gap is even wider for brand-name drugs, with U.S. prices averaging 3.44 times those of...
StrategyCalifornia Rx: State May Dive Into Generic Drug Market
A bill, SB-852, opens the door for California to make its own generic drugs in the future. Gov. Gavin Newsom...
Strategy2021 Health Plans Granted Leeway to Limit Consumers' Benefit from Drug Coupons
Advocates for consumers with chronic conditions say the rule will make it harder for patients who rely on very expensive...
StrategySandoz Will Pay $195M to Settle Price Fixing Charges
It's the seventh such settlement reached by DOJ's Antitrust Division in its ongoing probe of the generic pharmaceutical industry.
FinanceCalifornia's New Transparency Law Reveals Steep Rise In Wholesale Drug Prices
Generic drugs saw the largest median increase of 37.6% from 2017 through the first quarter of 2019.
FinanceLarge Chain Pharmacies Have Lowest Cash Prices for Generics, Less Variation
Consumers might be better off price shopping for generic prescription drugs, according to a new study.
StrategyDrugmakers Master Rolling Out Their Own Generics To Stifle Competition
Critics say authorized generics hurt long-term competition and often perversely increase costs, even in the short term.
Generic Drug Maker Heritage Pharmaceuticals Admits to Price Fixing
The Eatontown, New Jersey-based company will pay $7.1 million to resolve criminal and civil allegations, and will cooperate with an...
InnovationCivica Rx Opens New HQ in Utah
Lehi, Utah, referred to as 'Silicon Slopes,' was chosen because it is centrally located amid Utah's universities and has become...
Trump Administration Salutes Parade of Generic Drug Approvals, but Hundreds Aren't for Sale
The FDA has approved more than 1,600 generic drug applications since January 2017 ? about a third more than it...
StrategyPhRMA, AHA Trade Blame, Barbs on High Drug Prices
Drug makers launch PR campaign blaming higher drug costs on hospital markups. Hospitals call the claims 'a brazen misrepresentation of...